The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
Journal of Pharmacy & Pharmaceutical Sciences · 2023
DOI: 10.3389/jpps.2023.11234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, 2023. Verfasst von Mali Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Atherosclerosis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting women. Chinese herbs have been considered as an alternative treatment for PCOS, and Yi-mu-cao ( Leonuri Herba ) is one of the most commonly used herbs to treat PCOS, which can relieve symptoms of PCOS patients. But the mechanism of its treatment remains unclear.
Method
The main active ingredients and potential targets of Leonuri Herba were obtained by TCMSP and Swiss Target Forecast, and the related targets of PCOS were obtained by searching DrugBank, GeneCard and DisGeNet databases. The Protein-Protein Interaction (PPI) network was constructed using STRING database. GO and KEGG were used to detect the enrichment pathways of key targets. Cytoscape software was used to construct the component-target-pathway network, analyze the PPI network core, and verify the reliability of target binding by molecular docking technology.
Result
8 components and 116 targets of Leonuri Herba on PCOS were screened. Common targets mainly involve the Lipid and atherosclerosis, Endocrine resistance, AGE-RAGE signaling in diabetic complications and other signaling pathways. It is suggested that it can form multi-target and multi-pathway regulatory network through quercetin, kaempferol and other active substances to regulate endocrine disorders and reduce inflammatory response, so as to systematically improve PCOS. Molecular docking experiments showed that the active constituents of Leonurus had good binding activity with potential targets of PCOS.
Conclusion
In summary, this study elucidates the potential effect of Leonuri Herba on PCOS, which is helpful to provide reference for clinical practice. This is also conducive to the secondary development of motherwort and its monomer components, and precision medicine for PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zitieren
APA
Wu, M., Liu, H., Zhang, J., Dai, F., Gong, Y., & Cheng, Y. (2023). The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking. Journal of Pharmacy & Pharmaceutical Sciences. https://doi.org/10.3389/jpps.2023.11234
Vancouver
Wu M, Liu H, Zhang J, Dai F, Gong Y, Cheng Y. The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking. Journal of Pharmacy & Pharmaceutical Sciences. 2023. doi:10.3389/jpps.2023.11234
BibTeX
@article{Wu2023,
author = {Wu, Mali and Liu, Hua and Zhang, Jie and Dai, Fangfang and Gong, Yiping and Cheng, Yanxiang},
title = {The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2023},
doi = {10.3389/jpps.2023.11234}
}
EUVIMED